US panel rejects Avastin for breast cancer use
An expert panel urged the US Food and Drug Administration on Wednesday to strip the Roche-made drug Avastin of its label for use against breast cancer because it is neither safe nor effective.
An expert panel urged the US Food and Drug Administration on Wednesday to strip the Roche-made drug Avastin of its label for use against breast cancer because it is neither safe nor effective.
French pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving an offer that attracted only a fraction of Genzyme shares.
China's top online search engine Baidu has apologised on state television following a barrage of criticism by official media over allegedly fraudulent advertisements.
British pharmaceutical giant GlaxoSmithKline said Thursday it is paying 41 million dollars to settle allegations of poor drug quality at a manufacturing plant in Puerto Rico.
French pharmaceutical giant Sanofi-Aventis said on Wednesday that US competition authorities had not raised any objections to its hostile bid for US biotechnology group and rare disease specialist Genzyme.